Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety

Central nervous system (CNS) tumors are the most common solid malignancy in the pediatric population. Based on adoptive cellular therapy's clinical success against childhood leukemia and the preclinical efficacy against pediatric CNS tumors, chimeric antigen receptor (CAR) T cells offer hope of...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitanza, Nicholas A., Ronsley, Rebecca, Choe, Michelle, Henson, Casey, Breedt, Mandy, Barrios-Anderson, Adriel, Wein, Amy, Brown, Christopher, Beebe, Adam, Kong, Ada, Kirkey, Danielle, Lee, Brittany M., Leary, Sarah E.S., Crotty, Erin E., Hoeppner, Corrine, Holtzclaw, Susan, Wilson, Ashley L., Gustafson, Joshua A., Foster, Jessica B., Iliff, Jeffrey J., Goldstein, Hannah E., Browd, Samuel R., Lee, Amy, Ojemann, Jeffrey G., Pinto, Navin, Gust, Juliane, Gardner, Rebecca A., Jensen, Michael C., Hauptman, Jason S., Park, Julie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Pediatric Brain Tumor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823206/
https://www.ncbi.nlm.nih.gov/pubmed/36599192
http://dx.doi.org/10.1016/j.neo.2022.100870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823206/
https://www.ncbi.nlm.nih.gov/pubmed/36599192
http://dx.doi.org/10.1016/j.neo.2022.100870

Ejemplares similares